Economic Models of Colorectal Cancer Screening in Average-Risk Adults: Workshop Summary (2005)
Chapter: Appendix A Workshop Agenda: Economic Models of Colorectal Cancer Screening in Average-Risk Adults
Appendix A
Workshop Agenda: Economic Models of Colorectal Cancer Screening in Average-Risk Adults
Lecture Room
National Academy of Sciences Building
2101 Constitution Avenue NW
Washington, D.C. 20418
January 26–27, 2004
Day 1
|
8:30–9:00 |
Continental Breakfast, Lecture Room |
|
9:00–9:30 |
Welcome and Introduction to the Workshop Louise Russell, Ph.D., Rutgers University, Workshop Chair Martin Brown, Ph.D., National Cancer Institute, Workshop Co-Chair Judith Wagner, Ph.D., IOM Staff Officer |
PART I: COMPARING ECONOMIC MODELS OF CRC SCREENING
|
9:30–11:00 |
Overview of Five Leading Economic Models of CRC Screening The “Harvard Model”: Karen Kuntz, Sc.D., Harvard University The “Ladabaum Model”: Uri Ladabaum, M.D., University of California at San Francisco The “Miscan Model”: Marjolein van Ballegooijen, M.D., Erasmus University The “Vanderbilt Model”: Reid Ness, M.D., Vanderbilt University The “Vijan Model”: Sandeep Vijan, M.D., University of Michigan |
|
11:00–11:15 |
Break |
|
11:15–11:45 |
Results of a Pre-Workshop Comparative Modeling Exercise Michael Pignone, M.D., University of North Carolina |
|
11:45–12:45 |
Discussion |
|
12:45–1:15 |
Lunch |
PART II: CURRENT EVIDENCE ON COLORECTAL CANCER SCREENING
|
1:15–2:30 |
Evidence on Compliance (Q&A follows presentations) |
|
|
Current Evidence on Compliance Sally Vernon, Ph.D., University of Texas at Houston |
|
|
Recent Follow-up and Compliance Patterns of Medicare Patients Todd Anderson, M.S., Congressional Budget Office |
|
|
The Relationship Between Compliance and Capacity Laura Seeff, M.D., Centers for Disease Control |
|
2:30–3:15 |
Recent Findings on Test Performance Brian Mullhall, M.D., Walter Reed Army Hospital Q&A follows presentation |
|
3:15–3:30 |
Break |
|
3:30–4:15 |
Measuring the Cost of Screening, Follow-up, and Surveillance in Cost-Effectiveness Models Martin Brown, Ph.D. National Cancer Institute Q&A follows presentation |
|
4:15–5:00 |
Evidence on Effectiveness of Follow-up and Surveillance Strategies Deborah Schrag, M.D., Memorial Sloan Kettering Cancer Center Q&A follows presentation |
Day 2
|
8:30–9:00 |
Defining Issues: A Reprise of First Day’s Findings Martin Brown, Michael Pignone, and Judith Wagner |
PART III: MODELING THE NATURAL HISTORY OF COLORECTAL CANCER
|
9:00–9:45 |
Recent Evidence on Natural History T.R.Levin, M.D., Kaiser Permanente Division of Research Q&A follows presentation |
|
9:45–10:00 |
The NCI CISNET Project: An Overview of Goals, Methods, and Current Status Eric Feuer, Ph.D., National Cancer Institute |
|
10:00–10:15 |
Break |
|
10:15–11:15 |
Discussion of Issues in Modeling Natural History |
|
11:15–12:00 |
Modelers’ Forum: Next Steps, Unresolved Questions, Critical Information Needs Marjolein van Ballegooijen, Karen Kuntz, Sandeep Vijan, Reid Ness, Uri Ladabaum and Coauthors |
|
12:00–1:00 |
Discussion and Wrap-up |
|
1:00 |
Adjourn |
